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Chemical Carcinogenesis in the
Tracheobronchial Epithelium
by B. F. Trump,* E. M. McDowell* and C. C. Harrist
Some of the recent work in pulmonary carcinogenesis is briefly reviewed. Morphologic studies
of neoplastic and preneoplastic lesions of the human bronchi are compared with similar studies
of carcinogenesis and epithelial regeneration in the hamster trachea. These studies suggest that
bronchogenic carcinomas are typically complex mixtures of three basic phenotypes, the
epidermoid and the mucous and dense-core granulated (endocrine) phenotypes. Pure forms of
these phenotypes are rare, as different cells and even individual cells in single tumors express
more than one phenotype. The clinical significance of such phenotypic variability is not yet
known. Bronchial cell types which retain the capacity to divide include the mucous cell, the basal
cell and perhaps the dense-core granulated cell. Studies of epithelial regeneration and preneoplastic
lesions suggest that the mucous cell may be pivotal both in the response to injury and in
carcinogenesis. Cigarette smoking is believed to be the major etiologic factor in bronchogenic
carcinoma. Cigarette smoke contains initiators of carcinogenesis, but it contains a plethora of
probable promoters and cocarcinogens as well. It is hypothesized that cigarette smoke may both
initiate bronchial cells and promote carcinogenesis in cells which have previously been initiated
by smoke or other factors. It is further hypothesized that the mucous cell is the major target for
initiation and subsequent tumorigenesis. The ultimate phenotype(s) displayed by the tumor is
suggested to result from the effect of microenvironmental factors upon the initiated cell and its
progeny.
Introduction
The multiple phenotypes often encountered in de-
scriptions and classifications of human and animal
tracheobronchial neoplasms have long been baffling to
many pathologists. On the one hand, it has been very
difficult to separate these phenotypes into a rational
classification, since there has been little or no evidence
that morphologic characterizations are in any way
meaningful from the standpoint ofprevention, etiology,
treatment or prognosis. But on the other hand, recent
developments indicate that the tumor phenotype may
have important etiologic, therapeutic, and prognostic
significance. For example, small cell carcinomas appear
to be relatively more frequent in uranium miners who
smoke (1), adenocarcinomas appeartobeincreasing as a
proportion of the whole (2) and small cell carcinomas
with putative endocrine characteristics appear to be
susceptible to some newer chemotherapeutic protocols
(3).
Over the past several years, a variety of refined
approaches have been developed with which the pheno-
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typic characteristics ofhuman and experimental animal
tracheobronchial neoplasms can be characterized more
effectively. These include improved methods of light
microscopiccytochemistry, electronmicroscopy, immuno-
peroxidase techniques for a variety of hormonal and
other markers including fetal antigens, and in vitro
methods. At the same time, many developments have
occurred in the area ofanimal models which can now be
carefully compared with human neoplasms and the
evolution of tracheobronchial neoplasia further char-
acterized (4,5). Moreover, through the use of in vitro
cultures oftracheobronchial epitheliumfromhuman and
experimental animals, direct comparisons can now be
made in terms of preneoplasia and neoplasia (6,7).
We will confine our comments to neoplasms arising in
the tracheobronchial epithelium, excludingthe bronchi-
oles and alveoli. During the past several years we have
studied and characterized in detail approximately 250
human bronchial neoplasms and have compared these in
detail with animal models, specifically, the benzo(a)py-
rene-ferric oxide model in hamsters, developed by
Saffiotti and co-workers (8). We have also conducted
studies in vitro in both human and animal tracheo-
bronchial epithelium in order to describe the response
to carcinogens and promoters (9-17) and have been
engaged in studies of epithelial repair in the hamster
trachea in vivo (18-21). Some of the results of these
studies are briefly summarized in this review.TRUMP, McDOWELL AND HARRIS
StudyofHumanBronchialNeoplasia
Methods have been developed in our laboratories
whichpermit virtually anytechnique incellormolecular
biology, biochemistry and immunology to be applied to
studies of human tissues, in this case the tracheobron-
chial epithelium. We have reviewed these methods
elsewhere (7), and they are only briefly summarized
here.
Obtainment, Transport, Storage and Culture
Human tissues are obtained at the time ofsurgery or
immediate autopsy and transported in antibiotic-con-
taining L-15 medium to the laboratory. Depending on
temperature, tissues can be stored for various periods
oftime ranging up to several days at 0-40C, or they can
be frozen. In most cases, however, tissues are utilized
within 24 hr of obtainment. A variety of methods has
been utilized for explant culture ofpieces up to 1 cm on
a side for periods ofup to 1 year. Conditions have been
established which maximize differentiation of the
epithelium as well as conditions which permit maximum
celldivision. Recently Lechneretal. (22)havedeveloped
methods for long-term cell culture. We, therefore, have
a variety oftechniques which can permit explant or cell
culture and which allow evaluation of responses to
injury including carcinogen treatment.
Xenograft Methods
Pieces or cylinders of bronchi can be grafted sub-
cutaneously in the athymic or nude mouse (23). When
small tubes of segmental, subsegmental, or smaller
bronchi are utilized, the ends seal offand are covered by
the dividing epithelium. Following an initial period of
injury and organization, the graft becomes vascularized
and the respiratory epithelium is maintained for long
periods of time, up to 1 year. The secretory products,
containing abundant mucosubstances, accumulate in
the lumen ofthe graft. Ifflat pieces, i.e., 0.5 to 1 cm on
a side, are grafted subcutaneously, the epithelial cells
divide to line a cyst, the stroma ofwhich is provided by
the host. The epithelium lining the cyst becomes
differentiated into a very normal-appearing, mucus-
secreting pseudostratified columnar epithelium.
Utilizing such methods, one can study histogenesis of
human tumors in vitro and in xenografts and compare
results with animal tissues invitro, in grafts or in vivo.
Animal Models of Pulmonary
Neoplasia
Much work has been done on this subject during the
past 10 years. Many new models in vitro and in vivo
usingvarious species and different routes ofadministra-
tion have been developed. These have been extensively
reviewed by Nettesheim and Griesemer (24). Among
the more important in vivo animal models are those
involving inhalation, injection, transpleural insertion,
and systemic administration of carcinogens. In vitro
animal models have utilized both explant and cell
cultures exposed to carcinogens. Recently, in vivo, in
vitro, and in vivolin vitro models have been developed
(25). As mentioned elsewhere in this review, our
laboratory has characterized a hamster model of
tracheobronchial neoplasia (8) and compared it with
lesions in human bronchi (4,5,26,27).
Tumor Phenotypes in Human
Bronchial Neoplasia
A variety of cellular phenotypes, often mixed, is
found in human bronchial neoplasms. This has resulted
in various schemes for classification including the
classification sponsored by the World Health Organi-
zation (28) and one developed in our laboratory (Table
1). Note that in both classifications many phenotypic
mixtures are seen; in fact, in our experience in a
surgical series, the most common phenotype involves
mixtures of adeno- and epidermoid differentiation. In
several papers and recent reviews, we have summarized
the details of these classifications and their com-
parisons, which we do not attempt to repeat here
(16,27,29-32).
The principal phenotypes that can be recognized are
the epidermoid or "squamous carcinoma" phenotype;
the adenocarcinoma phenotype possessing dense-cored
granules which are presumed to represent an "endo-
crine" differentiation and the mucus-secreting adenocar-
cinoma phenotype. The adenocarcinoma phenotypes
can appear either with or without gross glandular
formation. Although the "pure" phenotypes are sum-
marized in Table 2, it is to be emphasized that these
very seldom if ever occur in actual tumors, as most if
not all have various mixtures of the three basic types.
By comparing the characteristics of the phenotypes in
Table 2 with the classifications in Table 1, the mixtures
of phenotypes can be deduced.
Preneoplastic Lesions and
Histogenesis
The histogenesis ofbronchial neoplasia in the human
still remains uncertain though in recent years detailed
studies of human neoplastic and preneoplastic lesions,
as well as parallel detailed studies of animal models,
have yielded much new information on their probable
mode of origin. In this section we will review some
current concepts in this area with a particular view
towards understanding so-called preneoplastic lesions.
By preneoplastic lesions we are referring to lesions that
occur prior to the development of invasive cancer in
both man and experimental models. Such lesions in the
bronchus include epidermoid (squamous) metaplasia
with and without atypia and carcinoma in situ. These
are considered to represent altered cell populations en
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Table 1. Comparison of phenotypic and WHO (1981) tumor typing.
Phenotypic






Combined epidermoid and adenocarcinoma (CEAC)
A. Epidermoid component well differentiated,
Adeno component well differentiated
B. Epidermoid component, well differentiated,
Adeno component poorly differentiated
C. Epidermoid component poorly differentiated,
Adeno component well differentiated
I. Tubular glands present, with or without mucus
II. Tubular glands minimal, with mucus
D. Epidermoid component, poorly differentiated,





I. Tubular glands present, with or without mucus
II. Tubular glands minimal, with mucus
Poorly differentiated
Tubular glands and mucus minimal
Small cells
Large cells




1. Squamous cell carcinoma
5. Adenosquamous carcinomab
2. Small cell carcinoma
4. Large cell carcinoma
7b. Mucoepidermoid carcinoma
1. Squamous cell carcinoma
5. Adenosquamous carcinomab
3a. Acinar adenocarcinoma
3d. Solid carcinoma with mucus
2. Small cell carcinoma
4. Large cell carcinoma
3a. Acinar adenocarcinoma
3d. Solid carcinoma with mucus
2. Small cell carcinoma
4. Large cell carcinoma
6. Carcinoid tumor
2. Small cell carcinoma
Atypical endocrine carcinomad 1. Squamous cell carcinoma
3d. Solid carcinoma with mucus
4. Large cell carcinoma
a Tumors with dense-cored granules stain positive for neuron-specific enolase; tumors without the granules do not stain for this
enzyme.
b Ducts lined by nonneoplastic Type II alveolar cells may be trapped in epidermoid cell nests giving the erroneous impression of
adenosquamous carcinoma.
e Some carcinoid tumors are mucus-secreting.
d Small cell carcinomas and atypical endocrine tumors may exhibit an epidermoid phenotype. Some tumors also secrete mucus.
Small cell tumors with epidermization and/or mucus secretion are called combined oat-cell carcinomas in the WHO classification.
Table 2. Lung tumor phenotypes: some phenotypic characteristics of "pure" bronchogenic carcinomas.a
Mucous Dense-core
Keratinb Lumens granules ER Mitochondria Golgi Desmosomes granules
Epidermoid carcinoma + + - - + Few ± + +
Adenocarcinomas
Mucosubstance type +/+ + + + + Numerous + + +
Dense-core granule type +/± - - + Variable + + +
a This table is meant to indicate the "pure" phenotypes of human bronchial neoplasia. It is to be emphasized that these neoplasms
do not typically occur in pure form, but instead usually exist as phenotypic mixtures.
b Keratohyaline in well-differentiated tumors.
route to malignant transformation. Most if not all of
these lesions appear to be reversible in both man and
experimental models. Currently carcinogenesis is con-
ceived as occurring in at least two and possibly multiple
stages. These are often termed initiation and promotion
(33). Initiation appears to involve genetic events
probablyinvolvingmutagenesis, forexample, formation
of carcinogen-DNA adducts, and it is considered to be
irreversible. Promotion, onthe otherhand, isreversible,
involves cell proliferation, ion shifts, e.g., Ca and/or Na
influx, induction of marker enzymes such as ornithine
decarboxylase (ODC), and possibly increased keratin
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formation in the cytoplasm (33). Many of the preneo-
plastic lesions in human and animal tracheobronchial
epithelium probably represent the action of promoters.
Many compounds, in addition to initiators, are found in
tobacco smoke and other effluents of combustion in
industrial environments. Some such putative promoters
in tobacco smoke include catechols, particulates, and
formaldehyde (1). If such promoters are applied to
human or animal tracheobronchial epithelium, lesions
closely resembling known preneoplastic lesions are
observed.
The Normal Tracheobronchial Epithelium
Tracheobronchial epithelia of humans and hamsters
appear to share many similarities (34,35). However,
certain differences, which may or may not be important,
appear to exist between the tracheobronchial epithelia
of rats and mice and humans.
It is important to recognize that the epithelium is
truly pseudostratified in the sense that all cells seem to
rest upon the basal lamina, but not all cells reach to the
lumen. Cell types found in the tracheobronchial epi-
thelium in man and animals are mucous cells, ciliated
cells, basal cells and endocrine cells.
Mucous cells are characterized by having variable
numbers of granules containing neutral and/or acidic
mucosubstances, usually in the cell apices. These vary
in number, from the numerous large granules which
distend the cell in the so-called goblet cells, to the small
inconspicuous granules found in what we have termed
small mucous granule cells, depending on the state of
the epithelium. Mucous cells rest on the basal lamina
and extend to the lumen. They have well-developed
rough endoplasmic reticulum and Golgi components,
numerous mitochondria and an electron dense cytosol
which distinguishes them even when only small portions
of the cells can be seen. The mucous cells of hamsters
seem to be similar to those in the human though the
granules are often somewhat more electron dense in
usual preparations. In the rat, cells which secrete
mucosubstances may be somewhat different both in
their electron microscopic (EM) and cytochemical char-
acteristics (36,37). Mucous cells are capable of incor-
porating thymidine and undergoing division; they may
be able to reconstitute the entire epithelium although
specific cloning experiments are needed to test that
hypothesis. They clearly seem to be ofgreatimportance
in tracheal wound healing (18-21).
Ciliated cells, in addition to having cilia, differ from
mucous cells in many ways. One of the useful charac-
teristics in their identification at the EM level, is the
electron lucency of their cytosol. This may imply
modification of ion and water content as well as a
decreased concentration of ribosomes and rough endo-
plasmicreticulum (ER). Ciliated cellsdo not incorporate
thymidine and certainly cannot divide without modi-
fication. Studies on ciliary amputation followed by
division have been performed in lower forms including
protozoa; the application ofthis principle to mammalian
respiratory ciliated cells has not been accomplished. In
the human, abnormalities of cilia commonly exist even
in putatively healthy individuals. Such abnormalities
include multiple axonemes within a single cytoplasmic
process, changes in the 9 + 2 arrangement (38) and
alterations in basal bodies. Ciliated cells also seemingly
have the property of easily dissociating from their
neighbors following injury to the epithelium and being
expectorated. We have recently found that treatment of
explanted hamster tracheobronchial epithelium with
amphotericin (39) results in abnormal cilia, possibly
because of increased cell Na and diminished Na-Ca
exchange and, therefore, increased cell Ca leading to a
modified cytoskeleton.
Basal cells are located along the basal lamina and do
not reach the lumen. They resemble mucous cells in the
electron density of the cytosol but in addition have
hemidesmosomes whichattachthemtothebasallamina.
They often contain abundant keratin filaments. Basal
cells incorporate thymidine and divide.
Scattered along the epithelium, sometimes reaching
the lumen and sometimes not, are cells which have
"dense-cored" granules. Presently it is not known
whether or not these cells are purely endocrine. The
frequency ofthese cells seems to differ not only during
growth and development but also between anatomic
sites within the airway and between species. In the
normal epithelium these cells divide infrequently and
apparently only in the fetal state. The granules are
argyrophilicand canbe demonstrated withthePAS-lead
hematoxylin technique ofSorokin and Hoyt (40). At one
time it was thought that these cells derived from
migration of neural crest cells during embryonic
development. This hypothesis has not been confirmed,
and many investigators presume today that they must
be derivatives of the original endodermal pouch which
ultimately forms the tracheobronchial epithelium.
Embryology of the Tracheobronchial
Epithelium
It is important to understand normal development of
the tracheobronchial epithelium, because manyfeatures
of development are recapitulated during epithelial
regeneration, preneoplasia, and neoplasia. Although
much remains to be learned about the details of
embryogenesis, there is general agreement in the
following. The early endodermal tubes which form the
lungare linedby asingle layerofunspecialized columnar
cells containing abundant glycogen. The epithelium
later becomes pseudostratified as ciliated, mucous,
endocrine, and basal cells develop. As this occurs,
glycogen is depleted. In the rabbit, primordial endo-
crine cells were the first specialized cells to be recog-
nized (41).
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Regeneration of the Tracheobronchial
Epithelium
In order to understand the cellular events that occur
duringthe development ofneoplastic lesions, it is useful
to examine those that occur during wound repair. There
have been a number of studies over the years and we
have recently reinvestigated and quantified this phe-
nomenon (18-21). Our model is the hamster trachea,
which exhibits morphologic similarity to the human
bronchial epithelium and which has been used in
carcinogenesis models reproducing rather faithfully the
portfolio of phenotypes seen in the human. The injury
that has been studied consists of simple mechanical
removal of a linear strip of epithelium using a blunt
probe. Using this technique the epithelium is entirely
removed down to the basal lamina at a focal point. The
events are characterized ad seriatum for periods of up
to 1 week. Colchicine blockade and tritiated thymidine
injections provide insight into the cellular kinetics
involved in the phenomenon.
Following the initial wound, an acute inflammatory
response occurs with a fibrinopurulent exudate. Within
the first few hours the cells at the margins ofthe wound
undergo a remarkable shape change from columnar to
squamous and soon begin migrating to cover the basal
lamina. This migration seems to involve mostly secre-
tory (mucous) cells, though occasional basal cells and
flattened ciliated cells with partially resorbed cilia can
be observed. It also appears that at this time many
ciliated cells are lost from the epithelium and are shed
into the lumen. Bundles of filaments (probably actin)
can be observed along the basilar aspects of the
migrating cells. It should be noted that these initial
events precede any cell division. By 24 hr the wound is
covered and numerous mitoses are arrested in meta-
phase after colchicine blockade. Thymidine incorpo-
ration is noted in both basal cells and secretory cells but
most mitoses occur in secretory cells. By 48 hr there is
piling up of the cells in the region of the wound,
producing typical epidermoid (squamous) metaplasia.
The cells contain abundant keratin filaments and the
epithelium is multilayered. Although the cells appear
typically epidermoid in that they contain keratin, they
also contain granules filled with mucosubstances.
Because ofthis and because ofthe significantly greater
number ofmitoses in secretory cells than basal cells, it
is inferred that these metaplastic cells are in large part
derivatives of secretory cells. Some contribution from
basal cells, however, cannot be totally excluded.
Some of the most superficial epidermoid metaplastic
cells slough from the epithelium and by 72 hr recon-
struction of the mucociliary epithelium is underway by
the genesis of presecretory and preciliated cells, from
division of mature secretory cells. Presecretory cells
mature into mucus secreting cells, whereas preciliated
cells show evidence ofciliogenesis at the cell apex in the
form of fibrogranular areas and later as basal bodies,
from which cilia develop. Over a period of 1 week, the
normal pseudostratified mucociliary epithelium is re-
stored (18-21).
It is apparent from these studies that epithelial
wound healing in the hamster tracheal epithelium
recapitulates some features of embryonic development
but also resembles features of preneoplastic lesions,
e.g., epidermoid metaplasia. It is not presently known
whether wounding per se constitutes a stimulus for
tumor promotion in the respiratory epithelium.
Preneoplastic Lesions
Severallines ofevidence indicate thathumanbroncho-
genic neoplasms develop following the appearance of a
series of preneoplastic cell populations. Evidence
includes case control studies on defined human popu-
lations, such as smoking uranium miners who were
followed by sputum cytology. In many cases, the
progressive cytologic change was followed for over 10
years priorto the development ofinvasive bronchogenic
carcinoma (42). These studies clearly show that a
definite progression occurs from epidermoid metaplasia
without atypia through epidermoid metaplasia with
atypia, thereafter developing carcinoma in situ, and
invasive cancer. It is evident that at any one phase of
the disease, all ofthe previous stages exist, but a clear
progression of the most advanced lesions can be
followed. The sequence of change in the bronchus is
thus rather similar to the progression ofcarcinomatous
change that occurs in the human uterine cervix. It is
significant that a similar, if not identical, sequence of
events occurs in the benzo(a)pyrene ferric oxide model
of bronchogenic carcinogenesis in the hamster (43).
On examining the so-called preneoplastic lesions in
greater detail, one ofthe earliest expressions ofchronic
injury to the tracheobronchial epithelium is the appear-
ance of numerous mucous cells, both goblet cells and
small mucous granule cells. In typical lesions, large
areas are free of ciliated cells. Since mucous cells can
divide, this lesion is best interpreted as a mucous cell
hyperplasia. Ciliated cells, as mentioned above, are
very susceptible to injury and frequently detach from
their neighbors, even while still alive and pass into the
airwaylumen. In some areas ofmucous cellhyperplasia,
more than one layer ofcells may be seen (26). Based on
animal studies and cytopathologic studies in humans,
the next lesions to appear, presumably a result ofmore
severe orlongerstandinginjury, are areas ofepidermoid
(squamous) metaplasia. These are frequently scattered
withinthebronchi, andoftenabrupttransitionsbetween
such areas and areas of mucous cell hyperplasia are
noted. In areas of epidermoid metaplasia, multiple
layers ofcellscontainingvariable amounts ofkeratin are
seen. Using stains for mucosubstances such as the
PAS-Alcian blue technique, many of the keratinizing
cells also contain mucosubstances (26,32). This occurs
not only in cells at the surface but in cells several layers
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down from the surface, thus approaching the basal
lamina. These small granules of mucosubstance can be
confirmed by EM cytochemistry. Already at this stage,
the cells begin to acquire new surface markers; for
example, carcinoembryonic antigen can be demon-
strated in areas of epidermoid metaplasia (16).
Tumor Promotion in the Tracheobronchial
Epithelium
The concept that carcinogenesis occurs in a stagewise
process has been suspected since the work of Rous and
Kidd (44), Berenblum (45), Mottram (46), and Boutwell
(47). All these investigators observed the effectiveness
of some hyperplasiogenic agents in promoting tumor
formation following subcarcinogenic exposure ofskin to
carcinogens, especially polycyclic aromatic hydrocar-
bons. Berenblum (45) introduced the use of croton oil
which contained very active tumor promoting agents,
and later Hecker (48) and van Duuren (49) identified
phorbol esters as the active components. Much of the
literature has been reviewed by Slaga et al. (50).
The multistage concept of carcinogenesis postulates
that the function of the initiator is to convert normal
cells into latent tumor cells, possibly through unex-
pressed mutagenic effects. Such latent neoplastic cells
persist for long periods of time-up to the lifetime of
the animal, unless exposed to a promoter. Subsequent
application of promoters results in hyperplasias and
many benign neoplasms which, in the case of mouse
skin, may regress, be retained, or progress to carcin-
omas. More carcinomas result as the dose of the
initiators is increased with a corresponding decrease in
the dose of promoter.
It should be emphasized that most knowledge and
theory concerning promotion are based on the mouse
skin system. Although this has been recently extended
to other organ systems in experimental animals,
including the liver and colon, experimental data are
lacking on the role of promoters in any human organ
system; the main clues so far come from epidemiologic
studies.
As pointed out by Potter (51), the concept of
promotionmay be veryimportantto ourcurrentconcept
of lung cancer as a result of cigarette smoking. In
human populations, many people may be exposed to
subcarcinogenic levels ofacarcinogen and neverdevelop
cancer in their lifetime, even though they may have a
substantial number of initiated cells. This possibility
appeared in an editorial in Lancet (52). In this regard,
Roe et al. (53) carried out experiments demonstrating
promoter activity in cigarette smoke condensates and
suggested that the relationship between smoking and
lung neoplasia might be determined principally by its
tumor promoting activity. Potter (51) concluded that
direct support for this conclusion comes from the
studies of Auerbach et al. (54), who made detailed
studies onthebronchiof216carefullymatchedsmokers,
former smokers, and nonsmokers who had died of
causes other thanlung cancer. They found that 93.2% of
the 3156 sections from 72 smokers contained atypical
cells, while only 6% of 3436 sections from 72 "former
smokers" contained such cells and only 1.2% of the
sections from nonsmokers showed atypical cells. Ham-
mond (55) expressed a theory ofcarcinogenesis which is
compatible with current concepts of initiation and
promotion, in that it involves both somatic mutation
(initiation) and hyperplasia, metaplasia, and atypia of
the bronchial epithelium in the smoke environment
(promotion). Hammond went on to infer that if an
individual ceases smoking, the more normal microen-
vironment results in reversal of the proliferated,
sometimes atypical cells (55).
In the skin, the most potent promoters are wounding
(56) and the fatty acid esters of phorbol. These esters
have strict structure-function relationships, their po-
tency in part determined by the length of fatty acid
ester groups, an optimum being about 14 carbons. The
most potent ofthe phorbol esters so far characterized is
12-0-tetradecanoylphorbol-13-acetate (TPA). This com-
pound is active both invivo and invitroinminute doses,
following which there are multiple biochemical and
morphologic changes. These include stimulation of
macromolecular synthesis leading to hyperplasia, stim-
ulation ofpolyamine synthesis, prostaglandin synthesis,
protease production, alterations of cell membrane
enzymes, phospholipids and glycoproteins, induction of
sister chromatid exchange, altered differentiation, and
altered responses to other growth controlling factors.
Many of these effects have been demonstrated in skin
and other cells in both experimental animals and man.
So far, the critical responses for tumor promotion have
not been determined; however, the pleiotropic effects
induced by these agents at nanomolar concentrations
and their discrete structure-activity relationships sug-
gest a hormone-like action.
There is a great need for expansion of knowledge
concerning the effects of cocarcinogens and promoters
in the tracheobronchial epithelium (25). A number of
cocarcinogens and promoters have been suspected or
identified in both human and experimental bronchial
neoplasia. These include several metals such as chro-
mium, nickel and arsenic; particulates such as asbestos
and ferric oxide; TPA; butylated hydroxytoluene (BHT)
in mouse pulmonary adenomas; and a long list of
compounds found in the gaseous and particulate phases
of tobacco smoke. In tobacco smoke there is a wide
varietyofcocarcinogens includingpyrene, fluoranthene,
benzo[g,h,i]perylene, benzo(e)pyrene, naphthalenes, 1-
methylindoles, 9-methylcarbazoles, 4-4'-dichlorostillbene
and catechol (1), and a variety of poorly characterized
acidic components in the gas phase which include for-
maldehyde, acrolein, acetaldehyde, and possibly the
ciliotoxic agentshydrogencyanideandcarbonmonoxide.
It is entirely conceivable that the principal carcinogenic
effect ofcigarette smokingisthe continuous exposure of
the bronchial epithelium to a wide variety ofpromoters
and cocarcinogens.
Recently, much attention has been directed in various
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tance ofrapid membrane and cytoskeletal alterations in
tumor promotion. Such effects include rapid influx of
Na followed by Ca, formation of superoxide radicals
which further modify the cell membrane, modulation of
cyclic AMP and cyclic GMP, modification of the cyto-
skeleton, and alteration of cell pH. We have recently
summarized evidence that modification of Ca, possibly
resultingfrom diminished Na-Caexchange, could result
in a number ofthe consequences including microtubule
dissolution with possible subsequent cell division, in-
creased expression of keratin filaments, activation of
protein kinases, and modification ofcell-cell interactions
specifically diminution of gap junctions (57). Such
modifications of cell ions might also be directly or
indirectly related to the increased numbers of "dark"
cells which occur in both skin and tracheobronchial
epithelium following TPA application (58,59).
Comments
It should be apparent from the foregoing that the
phenotypiccharacteristics ofhumanandanimaltracheo-
bronchial neoplasms are complex. This apparent com-
plexity may be important in that it reflects the histo-
genesis and possibly the etiologic risk factors and
prognosis.
A variety of recent studies indicate that the cellular
microenvironment can affect, if not determine, the
phenotypic characteristics ofcells. Forexample, vitamin
A deficiency is associated with epidermoid metaplasia,
while vitamin A excess results in excessive production
of mucus. Anoxia and ischemia (common in neoplasms)
are associated with increased intracellular calcium (57).
Growth of human bronchial epithelium in high Ca
mediumisassociated withincreased cytoplasmic keratin
(22) and treatment ofhamster trachea in vitro with the
Ca ionophore A23187 is associated with epidermoid
metaplasia (17). Such considerations lead us to believe
that the ultimate phenotype of human bronchial neo-
plasms is influenced largely by the microenvironment.
Whether or not these tumor phenotypes exert any
important influence on the biology of human bronchial
neoplasia remains to be determined. In the same
context, it has been reported that the phenotype of a
bronchial neoplasm can change as a function oftime in a
given patient. Furthermore, the phenotype of the
primary tumor may differ from that of the distant
metastases.
In any case, our studies lead us to believe that the
mucous cell ofthe tracheobronchial epithelium plays an
important role in wound repair, preneoplasia, and
neoplasia, which suggests that a high priority in the
future should be given to studies which are designed to
characterize the normal and abnormal biology of this
pivotal cell type. Furthermore, it appears from our
studies that although tumors can at least intheory arise
from any or all ofthe cells that are capable of division,
all of the phenotypes described in Table 2 can develop,
perhaps dependent on the environment and/or the risk
factors and carcinogens involved.
This work was supported in part by NCI Contract #N01-CP-15738
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